Skip to main content

Table 1 Effects of different luteolin/PLGA ratios on particle size, Zeta potential, DLC and EE of Lut-NPs (n = 3, mean ± SD)

From: HepG2 exosomes coated luteolin nanoparticles remodeling hepatic stellate cells and combination with sorafenib for the treatment of hepatocellular carcinoma

NO

Luteolin/PLGA (w/w)

Particle size (nm)

Zeta potential (mV)

DLC(%)

EE (%)

Luteolin

concentration

(mg/mL)

(%)

(mg/mg)

P1

5

0.526/10

112 ± 4

− 39 ± 1

1.4 ± 0.1

28.6 ± 1.9

0.15 ± 0.01

P2

4

0.420/10

115 ± 5

− 37 ± 1

2.3 ± 0.2

57.1 ± 3.6

0.24 ± 0.02

P3

3

0.310/10

115 ± 3

− 33 ± 3

2.0 ± 0.0

64.7 ± 1.0

0.20 ± 0.00

P4

4

0.210/5

93 ± 7

− 33 ± 2

2.5 ± 0.1

53.6 ± 2.9

0.11 ± 0.01

P5

4

0.840/20

Precipitation